ECBS is excited to host Gurleen Saini from Boehringer Ingelheim for a webinar on "Evaluation of Design of Experiment (DoE) framework in neutralizing antibody (nAb) assay development for multi-domain drugs" on 27th September (Friday) from 12:30-1:30 pm ET.
Meeting details are below:
Microsoft Teams meeting
Join on your computer, mobile app or room device
Click here to join the meeting
Meeting ID: 229 455 062 812
Passcode: 7KMVHD
Download Teams | Join on the web
Or call in (audio only)
+1 323-676-6166,,183463700# United States, Los Angeles
Phone Conference ID: 183 463 700#
Find a local number | Reset PIN
See you on Friday!
Regards
Afsana, Arkadeep, and Evan
------------------------------
Arkadeep Sinha, PhD
Director, Bioanalytical Sciences
Upstream Bio
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------